Anthropic Heads for an IPO: 825 Million Shares at $70–78 Could Raise Up to $64 Billion

Anthropic has officially begun its roadshow, meaning it has started presenting itself to investors ahead of its initial public offering. The company plans to offer 825 million shares, with a preliminary price range of $70 to $78 per share. At first glance this is financial news for stock traders. In practice, it matters to anyone who has already built Claude into a product or is considering doing so.

What that adds up to in dollars

The announcement gives the number of shares and the price, but not the total amount. Let's do the math ourselves: 825 million × $70 comes to about $57.8 billion, and 825 million × $78 comes to about $64.4 billion. That is an estimate based on the lower and upper ends of the range. The final price may shift, and details of the deal structure have not yet been disclosed.

Even at the low end, the offering is enormous. According to the source, it could become the second-largest in history. The record is held by SpaceX, which raised $86 billion in June 2026. That puts an AI lab on par, in terms of the size of its raise, with the biggest stock market debuts in the history of the market.

Why this matters beyond investors

Imagine you are building a product on the Claude API. Until now, all you saw was a price list and a status page. After the IPO, the provider will be obliged to disclose information: revenue, expenses, risks, dependence on large customers. For you, that is a chance to assess how resilient the business is that your product depends on.

The second factor is public-market pressure. Companies that report every quarter usually pay closer attention to margins and revenue predictability. How exactly this will affect API prices, limits and terms for enterprise customers is not yet known. But it is reasonable to assume that the provider's behavior will become more "financially disciplined," and to build that scenario into your plans.

The third factor is money for growth. A raise in the tens of billions of dollars potentially means resources for compute and research. Exactly what the funds will go toward will become clear from the offering documents; for now it is only speculation.

What developers and product managers should do

There is no need to panic or rush to move off Claude. But a few practical steps suggest themselves.

• Read the prospectus. Investor materials usually describe risks and the revenue structure. For you, it is free analysis of a provider you may be paying every month.
• Check your single-vendor dependence. If all of your product's logic is tied to one model, define a fallback: an abstraction layer over the provider, a quality test suite, and a clear migration plan.
• Watch pricing and terms. Any change after the IPO is a reason to recalculate the unit economics of your feature, especially if it relies on a large volume of tokens.
• For founders: the success of this offering sets a valuation benchmark for AI companies. It will influence how investors view your funding rounds and your competitors.

What is still unknown

The original report names no exchange, no trading date, no valuation for the whole company and no financial results. The price range is preliminary, and the outcome depends on demand during the roadshow. So it is too early to judge the long-term consequences: we know the scale of the deal, but not its substance.

The main takeaway is simple. The largest AI labs are turning from private startups into public companies with financial reporting and shareholders. For those building on their models, that means more transparency and, possibly, tougher commercial terms. The best thing to do now is study the documents as they appear and check in advance whether your product can survive a change in terms from your main provider.